化合物PF-03654764 T61213

Product Introduction
Bioactivity


英文名: PF-03654764

描述: PF-03654764 是一种具有口服活性、高效性和选择性的组胺 H3 受体拮抗剂，对人 H3 和大鼠 H3 具有抑制作用， Ki 值分别为 1.2 nM 和 7.9 nM。PF-03654764 常与 Fexofenadine 一起联合用药来治疗过敏性鼻炎。

体外活性: In a whole cell assay, PF-03654764 exhibits pKi values of 8.98 and 8.10 for human H3 and rat H3, respectively. In HEK-293 cells, PF-03654764 demonstrates pKi values of 8.84 and 7.73, as well as Ki values of 1.4 nM and 19 nM for human H3 and rat H3, respectively. Notably, PF-03654764 displays >1000-fold selectivity for the H3 receptor over the other histamine receptor subtypes[1].Regarding its pharmacokinetics, PF-03654764 has a half-life (T1/2) of 120 minutes in human liver microsomes (HLM) and a clearance (CLh) of less than 5 mL/min•kg in HLM[2].

体内活性: In Sprague-Dawley rats, PF-03654764 administered orally at a dose of 10 mL/kg for 14 days results in a Cmax of 8057 ng/mL and an AUC0-24 of 67400 ng•h/mL[2].Similarly, in beagle dogs, oral administration of PF-03654764 at a dose of 1 mL/kg for 7 days yields a Cmax of 6302 ng/mL and an AUC0-24 of 18175 ng•h/mL[2].

存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year

相关产品: Vapitadine | Fexofenadine hydrochloride | Impromidine hydrochloride | Mirtazapine | Dimenhydrinate | Oxatomide | Dothiepin | Latrepirdine dihydrochloride | Bepotastine | Mebhydrolin napadisylate

相关库: Membrane Protein-targeted Compound Library

化合物PF-03654764 T61213信息由TargetMol中国为您提供，如您想了解更多关于化合物PF-03654764 T61213报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途